glenmark - Latest News on glenmark | Read Breaking News on Zee News

Glenmark Q1 net at Rs 78 cr

Last Updated: Thursday, August 02, 2012, 23:24

Drug firm Glenmark Pharmaceuticals today posted a net profit of Rs 78.27 crore for the first quarter ended June 30, 2012.

Glenmark gets tentative nod from USFDA for migraine tablets

Last Updated: Wednesday, May 16, 2012, 14:49

Glenmark Pharmaceuticals Wednesday said it has received tentative approval from the US health regulator for generic Zolmitriptan tablets used for treating migraines.

Glenmark Q4 net up 33% at Rs 150 cr

Last Updated: Tuesday, May 08, 2012, 20:29

Glenmark Pharmaceuticals Tuesday said its consolidated net profit rose by 32.54 percent to Rs 150.35 crore for the fourth quarter ended March 31, 2012, on the back of robust sales in the domestic and US market.

Glenmark gets final USFDA nod for oral contraceptive pills

Last Updated: Tuesday, April 03, 2012, 14:03

Glenmark Pharmaceuticals on Tuesday said it has received final approval by the US health regulator to market its oral contraceptive Desogestrel and Ethinyl Estradiol tablets in the American market.

Glenmark recalls select lot of oral contraceptive in US

Last Updated: Saturday, February 25, 2012, 14:36

The recall is issued by the company's US arm Glenmark Generics Inc for tablets in strengths of 0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg, Glenmark Pharma said in a statement.

Glenmark Pharma dips nearly 7% on disappointing Q3 nos

Last Updated: Tuesday, January 31, 2012, 12:59

Shares of Glenmark Pharmaceuticals tumbled by nearly 7 percent on Tuesday after the company's net profit declined by 46.70 percent in the quarter ended December 31, 2011.

Glenmark Pharmaceuticals Q3 net dips 46.70% to Rs 46.11 cr

Last Updated: Monday, January 30, 2012, 18:09

Glenmark Pharmaceuticals on Monday said its consolidated net profit declined by 46.70 percent to Rs 46.11 crore for the quarter ended December 31, 2011 over the same period last fiscal due to forex loss.

Glenmark eyes 20% sales growth in India speciality biz in 3yrs

Last Updated: Sunday, January 15, 2012, 12:23

Glenmark Pharmaceuticals expects sales of its speciality business, which focuses on branded products, to grow by around 20 percent in India in the next three years.

Glenmark seeks arbitration after US co breaches pact

Last Updated: Tuesday, December 13, 2011, 13:50

Glenmark Pharmaceuticals said on Tuesday it has sought an arbitration in the US as Napo Pharmaceuticals has no basis for terminating a collaboration agreement with it to develop and market an HIV-associated diarrhoea drug.

Glenmark gets $5 mn payment from Sanofi-Aventis

Last Updated: Monday, November 07, 2011, 19:53

Drug firm Glenmark Pharmaceuticals Monday said it has received a payment of USD 5 million (over Rs 24 crore) from Sanofi-Aventis on completion of Phase I study of molecule.

Glenmark gets $15 mn from Salix for upgradation

Last Updated: Tuesday, July 26, 2011, 11:02

Glenmark Pharmaceuticals said on Tuesday it has received USD 15 million from US-based Salix Pharmaceuticals towards upgrading the manufacturing facility for HIV-associated diarrhea drug 'Crofelemer'.

Glenmark gets USFDA nod for anti-ulcer capsules

Last Updated: Monday, July 18, 2011, 13:56

Glenmark Pharmaceuticals Monday said it has received final approval from the US health regulator to market generic Nizatidine capsules, used for treating ulcers, in the American market.